Gene therapy includes use of DNA as a pharmaceutical agent to treat diseases. It promises to be one of the most important frontiers in medicine and a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections). In the recent scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development.
Gene therapy market is segmented by types, technology, applications, vectors and geography. On the basis of types the market is segmented into somatic gene therapy and germline gene therapy. On the basis of technology the market is further segmented by type of gene therapy, physical methods and chemical methods. On the basis of type of gene therapy the market is further segmented into ex vivo gene therapy and in vivo gene therapy. On the basis of physical methods the market is segmented into electroporation, microinjection, particle bombardment, ultrasound-mediated transfection, molecular vibration, laser irradiation, photochemical transfection. On the basis of chemical methods the market is further segmented into gene repair and replacement, gene editing by using short synthetic oligonucleotides, genome engineering by using TALENs, genome engineering by using CRISPR system, mRNA gene therapy, spliceosome mediated RNA trans-splicing. On the basis of application the market is segmented into oncology, infectious diseases, genetic disorders, cardiovascular disorders, diabetes mellitus, hypertension and neurological disorder. Based on geography the market is segmented into the North America, Europe, Asia and Rest of the World (RoW).
The growth is attributed to development in the gene silencing technology, increasing demand for gene therapy in immunodeficiency syndromes, growing popularity of DNA vaccines, and development in the nanotechnology. However, stringent regulatory laws in U.S. and Europe for gene therapy, side effects of gene therapy, Occurrence of Multigene Disorders in Gene Therapy and technical limitations are hindering the growth of this market.
The key players in this market are AnGes MG, Inc (Japan), Ark Therapeutics (U.K.), Ceregene, Inc (U.S.), Cobra Biologics (U.K.), GenVec, Inc (U.S.), Genzyme Corporation (U.S.), Vical, Inc. (U.S.), Oxford BioMedica (U.K.), BioSante Pharmaceuticals (U.S.), Transgene (France).
Decision Databases is involved in providing research reports and company profiles in the global gene therapy market in terms of revenue and output/volume. Market drivers, opportunities and restraints are thoroughly studied which influences the market. This study is further utilized for the overall analysis of the market. The gene therapy market is segmented based on the global applications, geographic presence, by products and ingredients. We offer an inclusive category-specific market outlook. We provide access to a comprehensive collection of companies in the industry. The companies can strategize and execute business operations through our competitor analysis. Find the global industry analysis, market size, share, growth, and trends information in our gene therapy profiles.
1.2 Objectives Of Study
1.3 Market Defination and Scope of the Study
1.3.1 Market Covered
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points from Secondary Sources
1.5.4 Key Data Points from Primary Sources
1.6 Auxillary Factors
1.8 List of Acronyms
2 Executive Summary
3 Market Overview
3.2 Market Dynamics
22.214.171.124 Development in the Gene Silencing Technology Driving the Growth of Gene Therapy Market
126.96.36.199 Increasing demand for Gene Therapy in Immunodeficiency Syndromes
188.8.131.52 Development in the Nanotechnology Propels the Growth of Gene Therapy Market
184.108.40.206 Growing Popularity of DNA Vaccines
220.127.116.11 Stringent Regulatory Laws in US and Europe
18.104.22.168 Immune Response to Gene Therapy
22.214.171.124 Occurrence Multigene Disorders in Gene Therapy
126.96.36.199 Side Effects of Gene Therapy
188.8.131.52 Technical Limitations
184.108.40.206 Development of New Thrapies based on Gene Therapy such as Combination of Gene Therapy and Stem Cell Technology
3.3 Market Share Analysis
4 Gene Therapy Market, By Type
4.1 Somatic Gene therapy
4.2 Germline Gene therapy
5 Gene Therapy Market, By Application
5.1 Genetic Disorders
5.2 Neurological Disorder
5.4 Cardiovascular Disorders
5.5 Diabetes Mellitus
5.6 Infectious Diseases
6 Gene Therapy Market, By Technology
6.1 Ex vivo and in vivo gene therapy
6.1.1 Ex vivo gene therapy
6.1.2 In vivo gene therapy
6.2 Physical methods
6.2.3 Particle bombardment
6.2.4 Ultrasound-mediated transfection
6.2.5 Molecular vibration
6.2.6 laser irradiation
6.2.7 Photochemical transfection
6.3 Chemical methods
6.3.1 Gene repair and replacement
6.3.2 Gene editing by using short synthetic oligonucleotides
6.3.3 Genome engineering by using TALENs
6.3.4 Genome engineering by using CRISPR system
6.3.4 mRNA gene therapy
6.3.6 Spliceosome mediated RNA trans-splicing
7 Gene Therapy Market, By Type of Vectors
7.1 Viral vectors
7.2 Retroviral vectors
7.3 Nonviral vectors
7.4 Artificial viral vectors
8 Geographic Analysis
8.1 North America
9 Competitive Landscape
9.1 Introduction (Overview)
9.2 Key Players in the Market
9.3 Competitive Situation and Trends
9.3.1 New Product Launches
9.3.2 Agreement, Collaborations, Partnerships, and Joint Ventures
10 Company Profiles
10.1 AnGes MG, Inc
10.2 Ark Therapeutics
10.3 Ceregene, Inc
10.4 Cobra Biologics
10.5 GenVec, Inc
10.6 Genzyme Corporation
10.7 Vical, Inc
10.8 Oxford BioMedica
10.9 BioSante Pharmaceuticals
10.10 Shenzhen SiBiono GeneTech Co., Ltd
The Global Tigecycline Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
The Global Risperidone Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure, read more..
The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers, read more..
The Radiopharmaceuticals Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method read more..
The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in read more..
The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..